| |
PRODUCT NAME |
ORDER |
 |
PHENYLALANINE |
 |
 |
1H-INDOLE-5-CARBOXAMIDE, 97% |
 |
 |
2-Propanamine,1-(2-pyrimidinyloxy)-(9CI) |
 |
 |
1H-Indole-4-carboxamide(9CI) |
 |
 |
1H-Imidazo[4,5-c]pyridine-4,6-diamine(9CI) |
 |
 |
Carbamic acid, [(3-hydroxycyclobutyl)methyl]-, 1,1-dimethylethyl ester (9CI) |
 |
 |
TERT-BUTYL TRANS-3-HYDROXYMETHYLCYCLOBUTYLCARBAMATE |
 |
 |
Cyclopentanamine, 3-[(aminooxy)methyl]-, cis- (9CI) |
 |
 |
Cyclohexanamine, 3-(aminooxy)-, cis- (9CI) |
 |
 |
Cyclohexanamine, 3-(aminooxy)-, trans- (9CI) |
 |
 |
Cyclohexanamine, 4-(aminooxy)-, cis- (9CI) |
 |
 |
Cyclohexanamine, 4-(aminooxy)-, trans- (9CI) |
 |
 |
2,2,6,6-Tetramethyl-4-piperidinyl stearate |
 |
 |
3-Pyrrolidinecarbonitrile,1-methyl-4-(1-propenyl)-,[3alpha,4beta(E)]-(9CI) |
 |
 |
2-Propenoicacid,3-(5-ethoxy-1,2-dioxolan-3-yl)-,methylester,[3alpha(Z),5bta]-(9CI) |
 |
 |
Carbamic acid, (2-fluorocyclopropyl)-, 1,1-dimethylethyl ester, (1S-trans)- (9CI) |
 |
 |
CYCLOHEXANONE DIETHYL ACETAL |
 |
 |
ETHYL N,N-DIMETHYLOXAMATE |
 |
 |
Oxetane, 2-(2-ethoxyphenyl)-3,3-dimethyl- (9CI) |
 |
 |
3,4-Furandiol, tetrahydro-4-(hydroxymethyl)-2-(5-methyl-1H-1,2,3-triazol-1-yl)-, (2R,3R,4R)- (9CI) |
 |
 |
Carbamic acid, (2-hydroxy-1-methylbutyl)-, 1,1-dimethylethyl ester, [R-(R*,S*)]- |
 |
 |
Carbamic acid, (2-hydroxy-1-methylbutyl)-, 1,1-dimethylethyl ester, [S-(R*,R*)]- |
 |
 |
6-Benzofuranol, 5-amino-7-methyl- |
 |
 |
1H-Indole-2-carboxylicacid,7-amino-,methylester(9CI) |
 |
 |
Pyrazino[2,1-c][1,4]benzoxazine, 1,2,3,4,4a,5-hexahydro- (9CI) |
 |
 |
Cobalt(III) hexafluoroacetylacetonate |
 |
 |
1-BOC-TRYPTAMINE |
 |
 |
Fmoc-D-Cys(Trt)-OH |
 |
 |
Benzamidine hydrochloride |
 |
 |
Carbamic acid, [(trimethylsilyl)oxy]-, ethyl ester (9CI) |
 |
 |
2H-Thiopyran-4-carboxamide,tetrahydro-(9CI) |
 |
 |
(2,6-DIMETHOXYPHENYL)METHANOL |
 |
 |
3aH-Benzimidazole(9CI) |
 |
 |
3-Azabicyclo[3.2.0]heptan-2-one,4-methyl-,[1S-(1alpha,4beta,5alpha)]-(9CI) |
 |
 |
4-(2-Piperidinoethoxy)benzoic acid hydrochloride |
 |
 |
Piperidine, 1-(2-pyrrolidinylcarbonyl)- (9CI) |
 |
 |
Hydrazinecarboxylic acid, 2-(2-pyridinyl)-, 1,1-dimethylethyl ester (9CI) |
 |
 |
3,4,6-Tri-O-benzyl-beta-D-mannopyranose-1,2-(methyl orthoacetate) |
 |
 |
3-Azabicyclo[3.2.1]octan-8-amine,3-(1-methylethyl)-(9CI) |
 |
 |
Bicyclo[2.2.1]heptane-2-carbonyl chloride, 2-methyl- (9CI) |
 |
 |
ALLYL(CHLOROPROPYL)DICHLOROSILANE |
 |
 |
1,11-DIBROMOUNDECANE |
 |
 |
5-(PHENYLSULFONYL)THIOPHENE-2-SULFONYL CHLORIDE; TECH., 90% |
 |
 |
4-BROMO-2,5-DICHLOROTHIOPHENE-3-SULFONYL CHLORIDE |
 |
 |
4-bromo-5-chlorothiophene-2-sulfonyl chloride |
 |
 |
5-(4-Chlorobenzamidomethyl)thiophene-2-sulphonyl chloride |
 |
 |
5-Chloro-3-methylbenzo[b]thiophene-2-sulphonyl chloride |
 |
 |
5-(1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)thiophene-2-sulfonyl chloride |
 |
 |
2,5-Dimethyl-3-furansulfonyl chloride |
 |
 |
1H-1,3-Diazepine-4-carboxylicacid,hexahydro-2-oxo-,(R)-(9CI) |
 |